Sort
39,280 grants matching “leukemia”
Molecular studies of Noonan syndrome and related disorders
$418,940Bruce D Gelb · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · HL
Potentiating Anti-WT1 responses by Targeting Peptide/MHC Complexes with T
$418,930David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA
Advancing biological and clinical applications of genomic Minimal Residual Disease detection in AML
$418,860Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Aberrant megakaryopoiesis in the myeloproliferative neoplasms.
$418,851John D Crispino · Northwestern University At Chicago · R01 · FY2020 · HL
Delineating how retinoic acids regulate lipid metabolism in glioblastoma and their resistance mechanisms
$418,800Deliang Guo · Ohio State University · R01 · FY2024 · CA
Transcriptional Networks Controlling Erythroid Differentiation
$418,750Gerd A Blobel · Children'S Hosp Of Philadelphia · R01 · FY2011 · DK
Hematopoietic regulation through Ott1-dependent alternative splicing
$418,750Glen D Raffel · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · HL
Role of Notch in Artery Development
$418,750Nathan D Lawson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · HL
Role of Notch in Artery Development
$418,750Nathan D Lawson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · HL
Hematopoietic regulation through Ott1-dependent alternative splicing
$418,750Glen D Raffel · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · HL
Epigenetic Control of Hematopoietic Gene Expression
$418,750Gerd A Blobel · Children'S Hosp Of Philadelphia · R37 · FY2010 · DK
Role of Notch in Artery Development
$418,750Nathan D Lawson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · HL
Mechanisms of adhesion and growth control in stem cells
$418,735Reuben Kapur · Indiana University Indianapolis · R01 · FY2009 · HL
Targeting the Unfolded Protein Response in Leukemia Biology and Chemotherapy Resistance
$418,613Stephen Matthew Sykes · Research Inst Of Fox Chase Can Ctr · R01 · FY2019 · CA
Developing a clinically-relevant genetically engineered mouse model for Nut carcinoma
$418,571Bin Gu · Michigan State University · R37 · FY2024 · CA
NanoOptogenetic immunotherapy for B cell lymphoma
$418,557Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · CA
Pathogenesis of Notch Leukemia
$418,530Brigham And Women'S Hospital · R01 · FY2004 · CA
Role of Inflammation in Tax-mediated Tumorigenesis
$418,523Lee Ratner · Ohio State University · P01 · FY2010 · CA
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$418,484Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2025 · CA
Deconvoluting Ras Signaling Networks in T Cell Lymphoma
$418,399Arup K. Chakraborty · Massachusetts Institute Of Technology · U54 · FY2009 · CA
Functional Genomic Dissection of Refractory Anemia
$418,384Todd R. Golub · Dana-Farber Cancer Inst · R01 · FY2007 · HL
Long distant regulation of c-myb in normal cells and acute myeloid leukemia
$418,383Linda Wolff · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Epigenetic Mechanisms Underpinning Mantle Cell Lymphoma Sensitivity and Resistance to Notch Inhibitors
$418,291Robert Babak Faryabi · University Of Pennsylvania · R01 · FY2025 · CA
The influence of genotype on the outcome of gene transfer in beta-thalassemia
$418,275Stefano Rivella · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · HL
Project 2: The cohesin complex as a tumor suppressor in myeloid leukemia
$418,251Ari M. Melnick · New York University School Of Medicine · P01 · FY2021 · CA